Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018 - 2024)

Historic Treasury Shares for Arcturus Therapeutics Holdings (ARCT) over the last 4 years, with Q4 2024 value amounting to $18786.0.

  • Arcturus Therapeutics Holdings' Treasury Shares changed 0.0% to $18786.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $18786.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $18786.0 for FY2024, which is 0.0% changed from last year.
  • As of Q4 2024, Arcturus Therapeutics Holdings' Treasury Shares stood at $18786.0, which was down 0.0% from $18786.0 recorded in Q4 2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Treasury Shares peaked at $18786.0 during Q4 2023, and registered a low of $18786.0 during Q4 2023.